| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Eeyarestatin I |
|---|
| Description | Potent inhibitor of endoplasmic reticulum associated protein degradation (ERAD). Specifically targets the p97-associated deubiquinating process (PAD) and inhibits ataxin-3 (atx3)-dependent deubiquitination. Also inhibits Sec61-mediated protein translocation at the ER. Displays cytotoxic activity preferentially against cancer cells; induces cell death via the proapoptotic protein NOXA. Purity 98%. MW (observed): 630.44 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(4-Chlorophenyl)-4-[[[(4-chlorophenyl)amino]carbonyl]hydroxyamino]-5,5-dimethyl-2-oxo-1-imidazolidineacetic acid 2-[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]hydrazide |
|---|
| Gene, Accession, CAS # | CAS: 412960-54-4 |
|---|
| Catalog # | 3922/10 |
|---|
| Price | |
|---|
| Order / More Info | Eeyarestatin I from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 25406314, 26074080, 27558430, 30254296 |
|---|
| 產(chǎn)品資料 |
|
|